Corvus Pharmaceuticals CRVS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$44.17M-6.7% | -$15.28M+75.5% | -$15.08M+73.5% | -$45.14M-99.6% | -$41.4M-66.5% | ||
| $112K+33.3% | $105K+23.5% | $99K+6.5% | $92K-9.8% | $84K-28.2% | ||
| $6.73M+88.8% | $5.33M+77.5% | $4.57M+65.4% | $4.05M+57.4% | $3.57M+52.1% | ||
| -$34.91M-22.4% | -$32.8M-29.0% | -$32.07M-44.9% | -$28.83M-35.7% | -$28.53M-36.0% | ||
| $229K— | $174K— | —— | —— | —— | ||
| —— | —— | -$24.76M— | -$26.03M— | -$23.23M— | ||
| $226.9M— | $36.43M— | $55.02M— | $54.71M— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$35.14M— | -$32.97M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Corvus Pharmaceuticals generate?
- Corvus Pharmaceuticals (CRVS) generated -$34.9M in operating cash flow over the trailing twelve months.
- What is Corvus Pharmaceuticals's free cash flow?
- After $229.0K of capital expenditures, Corvus Pharmaceuticals's free cash flow was -$35.1M over the trailing twelve months, down 45.7% year over year.
- Where does Corvus Pharmaceuticals's cash flow data come from?
- Every line is extracted from Corvus Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.